Evidence map›Paper›PMID 27087892›Full record

ArticleStandards in genomic sciences2016

Non contiguous-finished genome sequence and description of Microbacterium gorillae sp. nov.

Linda Hadjadj, Jaishriram Rathored, Mamadou Bhoye Keita, Caroline Michelle, Anthony Levasseur, Didier Raoult, Pierre-Edouard Fournier, Jean-Marc Rolain, Fadi Bittar

Abstract readCase Reports
In one paragraph

Article in Standards in genomic sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comparative Genomics ofFrontiers in microbiology · 2020
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Linda HadjadjUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Jaishriram RathoredUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Mamadou Bhoye KeitaUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Caroline MichelleUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Anthony LevasseurUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Didier RaoultUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France ; King Fahad Medical Research Center, King Abdul Aziz University, Jeddah, Saudi Arabia.
Pierre-Edouard FournierUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Jean-Marc RolainUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.
Fadi BittarUnité de recherche sur les maladies infectieuses et tropicales émergentes (URMITE), UM63, CNRS7278, IRD 198, Inserm 1095, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix-Marseille Université, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strain G3(T) (CSUR P207 = DSM 26203) was isolated from the fecal sample of a wild gorilla (Gorilla gorilla subsp gorilla) from Cameroon. It is a Gram-positive, facultative anaerobic short rod. This strain exhibits a 16S rRNA sequence similarity of 98.2 % with Microbacterium thalassium, the closest validly published Microbacterium species and member of the family Microbacteriaceae. Moreover, it shows a low MALDI-TOF-MS score (1.1 to 1.3) that does not allow any identification. Thus, it is likely that this strain represents a new species. Here we describe the phenotypic features of this organism, the complete genome sequence and annotation. The 3,692,770 bp long genome (one chromosome but no plasmid) contains 3,505 protein-coding and 61 RNA genes, including 4 rRNA genes. In addition, digital DNA-DNA hybridization values for the genome of the strain G3(T) against the closest Microbacterium genomes range between 19.7 to 20.5, once again confirming its new status as a new species. On the basis of these polyphasic data, consisting of phenotypic and genomic analyses, we propose the creation of Microbacterium gorillae sp. nov. that contains the strain G3(T).

Indexed as

CulturomicsGenomeGorilla stool sampleMicrobacterium gorillaeTaxonomo-genomics

Identifiers

PMID27087892
PMCPMC4832456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.